Clinical relevance of Proteus mirabilis in hospital patients: A two year survey

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 4, 2000, Pages 537-539

  De Champs, C ^a   Bonnet, R ^a   Sirot, D ^a   Chanal, C ^a   Sirot, J ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; PENICILLINASE;

ARTICLE; BACTERIUM ISOLATION; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; PROTEUS MIRABILIS; RETROSPECTIVE STUDY; URINE;

PROTEUS MIRABILIS;

EID: 0034037724     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.4.537     Document Type: Article

References (11)

1. Rozalski, A., Sidorczyk, Z. & Kotelko, K. (1997). Potential virulence factors of Proteus bacilli. Microbiology and Molecular Biology Reviews 61, 65-89.
2. De Champs, C., Sirot, D., Chanal, C., Sirot, J. & French Study Group (1999). A survey of extended-spectrum β-lactamase in Enterobacteriaceae in France. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 1485, p. 168. American Society for Microbiology, Washington, DC.
3. Mariotte, S., Nordmann, P. & Nicolas, M. H. (1994). Extended-spectrum β-lactamase in Proteus mirabilis. Journal of Antimicrobial Chemotherapy 33, 925-35.
4. Chanal, C., Sirot, D., Romaszko, J. P., Bret, L. & Sirot, J. (1996). Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 38, 127-32.
5. Bret, L., Chanal, C., Sirot, D., Labia, R. & Sirot, J. (1996). Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains. Journal of Antimicrobial Chemotherapy 38, 183-91.
6. Romaszko, J. P., Bret, L., Henquell, C., Sirot, D., Chanal, C. & Sirot, J. (1995) Detection of β-lactamases resistant to inhibitors (IRT) by the disk diffusion method. Pathologie Biologie 43, 306-9.
7. Sirot, J. (1996). Detection of extended-spectrum plasmid-mediated β-lactamases by disc diffusion. 1996 Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Clinical Microbiology and Infection 2, Suppl. 1, 35-9.
8. Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C. & Hughes, J. M. (1988). CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 16, 128-40.
9. Bouza, E., Pérez-Molina, J. & Munoz, P. (1999). Bloodstream infections in Europe. Report of ESGNI-001 and ESGNI-002 studies. On behalf of the Cooperative Group of the European Study Group on Nosocomial Infections (ESGNI). Clinical Microbiology and Infection 5, 2S01-12.
10. Nicolas-Chanoine, M. H., Chardon, H., Avril, J. L., Cattoen, Y., Croix, J. C., Dabernat, H. et al. (1997). Susceptibility of Enterobacteriaceae to betalactams and fluoroquinolones: a French multicenter study. Journal of Clinical Microbiology and Infection 3, Suppl. 2, Abstract P 338, 74.
11. Goldstein, F. W., Péan, Y., Rosato, A., Gertner, J. & Gutmann, L. (1993). Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group. Journal of Antimicrobial Chemotherapy 32, 595-603.